June 8, 2020
PA-20-135 - Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
National Institute of Nursing Research (NINR)
The purpose of this Notice is to inform applicants that the National Institute of Nursing Research (NINR) will participate, effective immediately, in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)".
The following changes and updates are made to PA-20-135 (shown in italics) to reflect NINR’s participation in this FOA.
Part 1. Overview Information
Components of Participating Organizations
National Cancer Institute (NCI)
National Center for Complementary and Integrative Health (NCCIH)
National Human Genome Research Institute (NHGRI)
National Institute of Allergy and Infectious Diseases (NIAID)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of General Medical Sciences (NIGMS)
National Institute on Minority Health and Health Disparities (NIMHD)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Office of Strategic Coordination ( Common Fund )
National Center for Advancing Translational Sciences (NCATS)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Nursing Research (NINR)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.213, 93.393, 93.394, 93.395, 93.396, 93.399, 93.172, 93.855, 93.865, 93.847, 93.113, 93.142, 93.143, 93.859, 93.307, 93.286, 93.350, 93.273, 93.310, 93.361
All other aspects of this Notice remain the same.
For any scientific or research-related questions on this emergency competitive revisions notice please contact the Program Officer listed on the NoA of the most recent parent award.